A Crystalline Variable Hydrate of (S)-6-(4-(2-((3-9H-Carbazol-4-Yloxy)-2-Hydroxypropyl)Amino)-2-Methylpropyl)Phenoxy)-3-Pyridinecarbox Amide Hemisuccinate Salt

摘要

The present invention relates to a crystalline variable hydrate of (S)-(3-pyridinecarboxamide,6-[4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl] amino]-2-methylpropyl]phenoxy]-hemi-succinate, a pharmaceutical formulation containing said salt and to methods for treating obesity and/or Type 2 diabetes using said salt.